Citadel Advisors’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.63M Sell
38,600
-13,900
-26% -$1.39M ﹤0.01% 4889
2025
Q4
$5.19M Buy
52,500
+26,100
+99% +$2.53M ﹤0.01% 4236
2025
Q3
$2.24M Buy
26,400
+15,800
+149% +$1.25M ﹤0.01% 5854
2025
Q2
$722K Sell
10,600
-60,700
-85% -$3.85M ﹤0.01% 7776
2025
Q1
$4.32M Sell
71,300
-70,700
-50% -$4.93M ﹤0.01% 4118
2024
Q4
$9.81M Sell
142,000
-500
-0.4% -$35.6K ﹤0.01% 3011
2024
Q3
$9.42M Sell
142,500
-23,800
-14% -$1.52M ﹤0.01% 2993
2024
Q2
$10.1M Buy
166,300
+41,200
+33% +$2.33M ﹤0.01% 2760
2024
Q1
$7.13M Buy
125,100
+70,900
+131% +$4.26M ﹤0.01% 3413
2023
Q4
$3.4M Buy
54,200
+2,400
+5% +$136K ﹤0.01% 4435
2023
Q3
$2.99M Sell
51,800
-82,200
-61% -$5.18M ﹤0.01% 4489
2023
Q2
$8.34M Buy
134,000
+104,500
+354% +$6.99M ﹤0.01% 2908
2023
Q1
$2.13M Sell
29,500
-27,600
-48% -$2.16M ﹤0.01% 5234
2022
Q4
$4.59M Buy
57,100
+4,100
+8% +$314K ﹤0.01% 3988
2022
Q3
$3.53M Sell
53,000
-18,300
-26% -$1.35M ﹤0.01% 4486
2022
Q2
$5.42M Sell
71,300
-99,500
-58% -$7.56M ﹤0.01% 3650
2022
Q1
$13.6M Buy
170,800
+13,600
+9% +$989K ﹤0.01% 2503
2021
Q4
$11.5M Sell
157,200
-97,200
-38% -$6.55M ﹤0.01% 2825
2021
Q3
$17.5M Buy
254,400
+126,300
+99% +$9.6M ﹤0.01% 2200
2021
Q2
$10.8M Buy
128,100
+3,700
+3% +$309K ﹤0.01% 2964
2021
Q1
$10.1M Buy
124,400
+37,200
+43% +$3.18M ﹤0.01% 2947
2020
Q4
$7.58M Sell
87,200
-13,000
-13% -$1.12M ﹤0.01% 3020
2020
Q3
$8.99M Sell
100,200
-30,600
-23% -$2.95M ﹤0.01% 2411
2020
Q2
$13.6M Sell
130,800
-44,600
-25% -$4.3M ﹤0.01% 1873
2020
Q1
$12.8M Sell
175,400
-7,000
-4% -$529K 0.01% 1624
2019
Q4
$15.9M Buy
182,400
+34,300
+23% +$2.93M 0.01% 1704
2019
Q3
$11M Buy
148,100
+28,600
+24% +$2.31M 0.01% 2107
2019
Q2
$10.2M Buy
119,500
+8,700
+8% +$698K ﹤0.01% 2162
2019
Q1
$9.53M Sell
110,800
-25,900
-19% -$2.11M ﹤0.01% 2141
2018
Q4
$8.69M Sell
136,700
-16,600
-11% -$1.08M ﹤0.01% 2074
2018
Q3
$10.6M Sell
153,300
-123,900
-45% -$8.5M ﹤0.01% 2032
2018
Q2
$18.6M Sell
277,200
-153,900
-36% -$10.5M 0.01% 1369
2018
Q1
$35.9M Buy
431,100
+221,300
+105% +$20M 0.02% 761
2017
Q4
$19.9M Buy
209,800
+106,500
+103% +$11.1M 0.01% 1157
2017
Q3
$12.1M Buy
103,300
+37,300
+57% +$4.72M 0.01% 1440
2017
Q2
$8.31M Buy
66,000
+25,600
+63% +$3.26M 0.01% 1605
2017
Q1
$5.4M Sell
40,400
-17,800
-31% -$2.27M ﹤0.01% 1960
2016
Q4
$5.84M Sell
58,200
-8,300
-12% -$810K 0.01% 1829
2016
Q3
$6.27M Buy
66,500
+17,400
+35% +$1.47M 0.01% 1756
2016
Q2
$3.93M Buy
49,100
+3,700
+8% +$287K ﹤0.01% 2039
2016
Q1
$3.29M Sell
45,400
-12,900
-22% -$961K ﹤0.01% 2171
2015
Q4
$6.32M Sell
58,300
-4,000
-6% -$446K 0.01% 1620
2015
Q3
$6.87M Buy
62,300
+19,400
+45% +$2.18M 0.01% 1625
2015
Q2
$4.47M Buy
42,900
+12,000
+39% +$1.24M ﹤0.01% 2174
2015
Q1
$2.83M Sell
30,900
-8,600
-22% -$711K ﹤0.01% 2657
2014
Q4
$2.89M Buy
39,500
+8,300
+27% +$542K ﹤0.01% 2520
2014
Q3
$1.53M Sell
31,200
-6,000
-16% -$301K ﹤0.01% 3182
2014
Q2
$2.1M Sell
37,200
-35,500
-49% -$1.81M ﹤0.01% 2693
2014
Q1
$3.89M Sell
72,700
-11,700
-14% -$726K ﹤0.01% 2003
2013
Q4
$4.27M Buy
84,400
+25,500
+43% +$1.11M 0.01% 1823
2013
Q3
$2.25M Buy
58,900
+29,900
+103% +$883K ﹤0.01% 2300
2013
Q2
$638K Buy
+29,000
New +$634K ﹤0.01% 3610

Other funds holding INCY

Citadel Advisors's INCY Position: Q1 2026 in Review

Citadel Advisors reduced its Incyte (INCY) stake by 26% in Q1 2026, selling an estimated $1.73M and leaving 49,284 shares worth $4.64M. The position accounts for ﹤0.01% of the portfolio, ranked #4465.

Citadel Advisors first reported a position in INCY in Q2 2013 and has held it in 50 quarters since. The position peaked at $221M in Q4 2016. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • Citadel Advisors held 49,284 shares of Incyte worth $4.64M as of Q1 2026.
  • Citadel Advisors sold 17,333 Incyte shares in Q1 2026, an estimated $1.73M.
  • Incyte made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4465 holding.
  • Citadel Advisors first reported a position in Incyte in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Incyte position peaked at $221M in Q4 2016.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.